Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration‐QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy VolunteersAndreas Becker, Andreas Johne|Clinical and Translational Science|2019Cited by 35